These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 5400583)

  • 21. [Immunomodulatory effect of Freund's incomplete adjuvant in patients with incipient forms of rheumatoid polyarthritis].
    Niculescu D; Naghiu M; Andronescu V; Dene A; Galatiuc C; Hălălău F; Belaşcu I; Sulica A
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1986; 38(5):467-78. PubMed ID: 2881337
    [No Abstract]   [Full Text] [Related]  

  • 22. Peripheral inflammation and neuroprotection: systemic pretreatment with complete Freund's adjuvant reduces 6-hydroxydopamine toxicity in a rodent model of Parkinson's disease.
    Armentero MT; Levandis G; Nappi G; Bazzini E; Blandini F
    Neurobiol Dis; 2006 Dec; 24(3):492-505. PubMed ID: 17023164
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Freund's complete adjuvant has a negative impact on egg laying frequency in immunised chickens.
    Bollen LS; Hau J
    In Vivo; 1999; 13(1):107-8. PubMed ID: 10218142
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [New therapeutic experiments in metastasizing melanoma].
    Gartmann H
    Hippokrates; 1970 Dec; 41(4):532-4. PubMed ID: 5496347
    [No Abstract]   [Full Text] [Related]  

  • 25. [Study of transfer of allergic encephalomyelitis].
    Orlov AB
    Vestn Akad Med Nauk SSSR; 1967; 22(2):83-5. PubMed ID: 5620909
    [No Abstract]   [Full Text] [Related]  

  • 26. The role of the thymus in the pathogenesis of adjuvant-induced polyarthritis in rats.
    Ryzewska A; Dabrowski M
    Arch Immunol Ther Exp (Warsz); 1968; 16(5):747-56. PubMed ID: 5709629
    [No Abstract]   [Full Text] [Related]  

  • 27. Comparison of Montanide adjuvants, IMS 3012 (Nanoparticle), ISA 206 and ISA 35 (Emulsion based) along with incomplete Freund's adjuvant for hyperimmunization of equines used for production of polyvalent snake antivenom.
    Waghmare A; Deopurkar RL; Salvi N; Khadilkar M; Kalolikar M; Gade SK
    Vaccine; 2009 Feb; 27(7):1067-72. PubMed ID: 19100805
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Complete Freund's adjuvant immunization prolongs survival in experimental prion disease in mice.
    Tal Y; Souan L; Cohen IR; Meiner Z; Taraboulos A; Mor F
    J Neurosci Res; 2003 Jan; 71(2):286-90. PubMed ID: 12503092
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunology. Diabetes studies conflict on power of spleen cells.
    Couzin J
    Science; 2006 Mar; 311(5768):1694. PubMed ID: 16556811
    [No Abstract]   [Full Text] [Related]  

  • 30. Comparison of immune and adverse effects induced by AdjuVac and Freund's complete adjuvant in New Zealand white rabbits (Oryctolagus cuniculus).
    Powers JG; Nash PB; Rhyan JC; Yoder CA; Miller LA
    Lab Anim (NY); 2007 Oct; 36(9):51-8. PubMed ID: 17885664
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CpG motif-based adjuvant as a replacement for Freund's complete adjuvant in a recombinant LHRH vaccine.
    Conforti VA; de Avila DM; Cummings NS; Zanella R; Wells KJ; Ulker H; Reeves JJ
    Vaccine; 2008 Feb; 26(7):907-13. PubMed ID: 18201806
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Studies on the effect of smallpox vaccine and Freund's adjuvant on the Harding-Passey melanoma in the mouse].
    Schwab B
    Arch Dermatol Forsch; 1971; 241(4):411-25. PubMed ID: 5127773
    [No Abstract]   [Full Text] [Related]  

  • 33. Experimental modulation of the reactivity of pleural milky spots (Kampmeier's foci) by Freund's adjuvants, betamethasone and mycobacterial infection.
    Pereira Ade D; Aguas AP; Oliveira MJ; Cabral JM; Grande NR
    J Anat; 1994 Dec; 185 ( Pt 3)(Pt 3):471-9. PubMed ID: 7649783
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Permanent reversal of diabetes in NOD mice.
    Faustman DL
    Science; 2007 Jul; 317(5835):196. PubMed ID: 17626866
    [No Abstract]   [Full Text] [Related]  

  • 35. [Mechanisms of action of specific hyposensitizing therapy].
    Ricci M
    Folia Allergol (Roma); 1969; 16(4):418-20. PubMed ID: 5400581
    [No Abstract]   [Full Text] [Related]  

  • 36. Surgical adjuvant immunotherapy for lung cancer: a review.
    Takita H
    Curr Surg; 1984; 41(4):254-61. PubMed ID: 6383721
    [No Abstract]   [Full Text] [Related]  

  • 37. [Current aspects of specific hyposensitizing therapy. Introduction].
    Serafini U
    Folia Allergol (Roma); 1969; 16(4):413-7. PubMed ID: 5400580
    [No Abstract]   [Full Text] [Related]  

  • 38. Delayed-type hypersensitivity in rabbits. Comparison of the adjuvants dimethyl dioctadecyl ammonium bromide and Freund's complete adjuvant.
    Snippe H; de Reuver MJ; Beunder JW; van der Meer JB; van Wichen DF; Willers JM
    Int Arch Allergy Appl Immunol; 1982; 67(2):139-44. PubMed ID: 6173338
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [AUTOLOGOUS DELAYED HYPERSENSITIVITY INDUCED IN THE RAT BY INTRATESTICULAR INJECTION OF FREUD'S ADJUVANT SUBSTANCE].
    EYQUEM A; LEVADITI J; DESTOMBES P; KRIEG H
    C R Hebd Seances Acad Sci; 1964 May; 258():5119-21. PubMed ID: 14150941
    [No Abstract]   [Full Text] [Related]  

  • 40. Determinant specific suppression of antigen-induced T cell proliferation in the guinea pig. I. Quantitation of suppressed antigen-specific T cell responses as a consequence of prior exposure to antigen in incomplete Freund's adjuvant.
    Baskin BL; Rosenthal AS
    J Immunol; 1980 Jan; 124(1):184-8. PubMed ID: 6153094
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.